Views
8 years ago

Volumen III - T. del ánimo: Bipoladirar 5/2011

  • Text
  • Trastornos
  • Pacientes
  • Epilepsia
  • Bipolar
  • Tratamiento
  • Litio
  • Trastorno
  • Dosis
  • Efectos
Tratado de Psicofarmacología y Neurociencia Volumen III Trastornos del estado de ánimo: Bipolaridad Trastornos psiquiátricos y cognitivos en la epilepsia

H Bertera, L Pérez

H Bertera, L Pérez Millán - Estabilizadores del estado de ánimo. Parte I. LitioReferencias bibliográficas1. Cade JF: Lithium salts in the treatment of psychotic excitement. Med J Aust 36:349-352, 1949.2. Berridge MJ, Downes CP, Hanley RR: Neural and developmental action of lithium: a unifyinghypothesis. Cell 59:411-419, 1989.3. Drevets WC, Price JL, Simpson JR Jr, et al: Subgenual prefrontal cortex abnormalities in mooddisordes. Nature 38:824-827, 1997.4. Ketter TA, George MS, Kimbrell TA, et al: Neuroanatomical models and brain imaging studies inbipolar disorder, in Biological Models and Their Clinical Application. Edited by Young JT, Joffe RT.New York. Marcel Dekker, pp 179-217, 1997.5. Manji HK, Etcheberrigeray R, Chen G, et al: Lithium decreases membrane-associated proteinkinase C in hippocampus: selectivity for the alpha isozyme. J Neurochem 61:2303-2310, 1993.6. Rajkowska G, Miguel-Hidalgo JJ, Wei J, et al: Morphometric evidence for neuronal and glial prefrontalcell pathology in major depression. Biol Psychiatry 45:1085-1098, 1999.7. Finley P, Warner M, Peabody C: Clinical relevance of drug interactions with lithium. ClinPharmacokinet 29:172-191, 1995.8. Kilts CD: In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium. J ClinPsychiatry 61:41-46, 2000.9. Stoll AL, Locke CA, Vuckovic A, et al: Lithium-associated cognitive and functional déficits reducedby a switch to divalproex sodium: a case series. J Clin Psychiatry 57:356-359, 1996.10. Gelenberg A J; Jefferson J W: Lithium tremor. The Journal of clinical psychiatry 56(7):283-7, 1995.11. Jefferson J W: Lithium tremor and caffeine intake: two cases of drinking less and shaking more.J Clin Psychiatry 49:72-73, 1988.12. Donaldson IM, Cuningham J: Persisting neurologic séquela of lithium carbonate therapy. ArchNeurol 40:747-751, 1983.13. Kirov G, Tredget J, Rhys J, Owen M, Lazarus J: A cross-sectional and prospective study ofthyroid disorders in lithium-treated patients. J Affect Disord 87:313-317, 2005.14. Bocchetta A, Mossa P, Veluzzi F, Mariotti S, Del Zompo M, Loviselli A: Ten year follow up ofthyroid function in lithium patients. J Clin Psycopharmacol 21(6):594-598, 2001.15. Bocchetta A, Cocco F, Velluzi F, Del Zompo M, Meriotti S, Loiselli A. Fifteen year follow up ofthyroid function in lithium patients. J Endocrinol Invest 30:363-366, 2007.16. Cayköylü A, Capoglu I, Ünúvar N, Erdem F, Cetinkara R: Thyroid abnormalities in litiumtreatedpatients with bipolar affective disorder. The J Int Med Res 30(1):80-84, 2002.17. Valle J, Ayuso-Gutierrez J, Abril A, Ayuso-Mateos J: Evaluation of thyroid function in lithiumnaive bipolar patients. Eur Psychiatry 14:341-5, 1999.18. Bocchetta A, Mossa P, Velluzi F, et al.: Ten-year follow up of thyroid function in lithium patients.J Clin Phsychopharmacol 21:594-598, 2001.19. Bauer M, Whydrow P, Winokur A: Rapid cycling bipolar affective disorder I. Association withgrade I hypothyroidism. Arch Gen Psychiatry 7 (5):427-430, 1990.20. Stancer HC, Persad E: Treatment of intractable rapid cycling maniac depressive disorder withlevothyroxine: clinical observations. Arch Gen Psychiatry 39:311-312, 1982.21. Aizemberg D,Sigler M, Zemishlani Z, et al: Lithium and male sexual function in affectivepatients. Clin Neuropharmacol 19:515-519, 1996.22. Bendz H, Aurell M: Drug-induced diabetes insipidus: incidence, prevention and management.EDITORIAL SCIENS53

LM Zieher - MC Brió // Tratado de Psicofarmacología y Neurociencia, Volumen III, Trastornos del estado de ánimo: bipolaridad. Trastornos psiquiátricos y cognitivos en la epilepsiaDrug Saf 21:449-456, 1999.23. Gitlin M: Lithium and the kidney: an updated review. Drug Saf 20:231-243, 1999.24. American Psychiatric Association: Practice guideline for the treatment of patients with bipolardisorder (revision). Am J Psychiatry 159 (suppl):1-50, 2002.25. Fenves AZ, Emmet M, White MG: Lithium intoxication associated with acute renal failure. SouthMed J 77:1472-1474, 1984.26. Kallner G, Petterson U: Renal, thyroid and parathyroid function during lithium treatment: laboratorytests in 207 people treated for 1-30 years. Acta Psychiatr Scand 91:48-51, 199527. Hetmar O: The impact of long-term lithium treatment on renal function and structure. ActaPsychiatr Scand Suppl 345:85-89, 1988.28. Mitchell JE, Mackenzie TB: Cardiac effects on lithium therapy in man: a review. J Clin Psychiatry43:47-51, 1982.29. Dumovic P, Borrows GD, Chamberlain K, et al: Effect of therapeutic dosage of lithium on theheart. Br J Clin Pharmacol 9:599-604, 1980.30. Martin CA, Piascik MT: First-degree A-V block in patients on lithium carbonate. Can JPsychiatry 30:114-116, 1985.31. Steckler TL: Lithium- and carbamazepine-associated sinus node dysfunction: nine-year experiencein a psychiatric hospital. J Clin Psychopharmacol 14:336-339, 1994.32. Tilkian AG, Schroeder JS, Kao JJ, et al: The cardiovascular effects of lithium in man: a reviewof the literature. Am J Med 61:665-670, 1976.33. Freeman MP, Stoll AL: Mood stabilizers in combination: a review of safety and efficacy. Am JPsychiatry 155:12-21, 1998.34. Lenox RH, McNamara RK, Watterson JM, et al: Myristoylated alanine-rich C kinase substrate(MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain? J ClinPsychiatry 57 (suppl 13):23-31, 1996.35. Johnson AG, Seiderman P, Day RO: Adverse drug interactions with nonsteroidal anti-inflammatorydrugs (NSAIDs): recognition, management and avoidance. Drug Saf 8:99-127, 199336. Finley P, Warner M, Peabody C: Clinical relevance of drug interactions with lithium. ClinPharmacokinet 29:172-191, 1995.37. DasGupta K, Jefferson JW, Kobak KA, et al: The effect of enalapril on serum lithium levels inhealthy men. J Clin Psychiatry 53(11):398-400, 1992.38. Finley PR, O’Brien JG, Coleman RW: Lithium and angiotensin-covering enzyme inhibitors: evaluationof a potential interaction. J Clin Psychopharmacol 16(1):68-71, 1996.39. Speirs J, Hirsch SR: Severe lithium toxicity with "normal" serum concentrations. Br Med J 1(6116):815-816, 1978.40. Kondziela JR: Extreme lithium intoxication without severe symptoms. Hosp CommunityPsychiatry 35: 727-728, 1984.41. Sadosty AT, Groleau GA, Atcherson MM: The use of lithium levels in the emergency department.J Emerg Med 17:887-891, 1999.42. Donaldson IM, Cuningham J: Persisting neurologic séquela of lithium carbonate therapy. ArchNeurol 40:747-751, 1983.43. Stoll AL, Locke CA, Vuckovic A, et al: Lithium-associated cognitive and functional déficits reducedby a switch to divalproex sodium: a case series. J Clin Psychiatry 57:356-359, 1996.44. Bowden CL, Brugger AM, Swann AC, et al: Efficacy of divalproex vs. lithium and placebo in the54

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015